AcelRx Pharmaceuticals
ACRX
$0.57
Share price
4.27%
Change (1 day)
-86.97%
Change (1 year)
Categories
EPS for AcelRx Pharmaceuticals (ACRX)
EPS in 2023 (TTM): -$3.09
According to AcelRx Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$3.09. In 2022 the company made an earnings per share (EPS) of $5.45 an increase over its 2021 EPS that were of -$5.80.
EPS history for AcelRx Pharmaceuticals from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.09 | -156.7% |
| 2022 | $5.45 | -193.97% |
| 2021 | -$5.80 | -39.58% |
| 2020 | -$9.60 | -28.36% |
| 2019 | -$13.40 | -18.29% |
| 2018 | -$16.40 | -25.45% |
| 2017 | -$22.00 | 17.02% |
| 2016 | -$18.80 | 67.86% |
| 2015 | -$11.20 | -26.32% |
| 2014 | -$15.20 | 15.15% |
| 2013 | -$13.20 | -56.29% |
| 2012 | -$30.20 | 27.97% |
| 2011 | -$23.60 | -92.99% |
| 2010 | -$336.44 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Cara Therapeutics
CARA | -$2.06 | -33.33% | 🇺🇸 USA |